Silybin ameliorates lipid metabolism disorders in mice with non-alco-holic steatohepatitis
CAI Zuhuan1, DENG Taomei1, WEI Naijie1, ZHU Dan2, QIAN Fei2, WANG Guangji1, ZHANG Jingwei1
1Key Laboratory of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, Jiangsu, China; 2Jiangsu Provincial Hospital of Chinese Medicine, Affiliated to Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu, China
CAI Zuhuan, DENG Taomei, WEI Naijie, ZHU Dan, QIAN Fei, WANG Guangji, ZHANG Jingwei. Silybin ameliorates lipid metabolism disorders in mice with non-alco-holic steatohepatitis[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 241-248.